Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,426 | 292 | 99.9% |
| Education | $5.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $527.70 | 32 | $0 (2024) |
| ABBVIE INC. | $474.51 | 30 | $0 (2024) |
| Novo Nordisk Inc | $440.06 | 30 | $0 (2024) |
| PFIZER INC. | $302.33 | 27 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $289.71 | 19 | $0 (2021) |
| GlaxoSmithKline, LLC. | $277.42 | 19 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $275.39 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $269.68 | 15 | $0 (2021) |
| Lilly USA, LLC | $132.80 | 9 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $128.32 | 9 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $529.01 | 31 | Amgen Inc. ($100.33) |
| 2023 | $257.56 | 14 | Novo Nordisk Inc ($78.48) |
| 2022 | $114.31 | 8 | ABBVIE INC. ($41.71) |
| 2021 | $339.64 | 22 | AbbVie Inc. ($74.92) |
| 2020 | $302.05 | 18 | Janssen Pharmaceuticals, Inc ($86.98) |
| 2019 | $895.28 | 60 | Amgen Inc. ($148.25) |
| 2018 | $884.22 | 63 | AbbVie, Inc. ($126.02) |
| 2017 | $1,109 | 77 | AstraZeneca Pharmaceuticals LP ($179.06) |
All Payment Transactions
293 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/25/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: PAIN | ||||||
| 11/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: VACCINE | ||||||
| 11/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Biological | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: DIABETES | ||||||
| 10/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Diabetes Care | ||||||
| 10/07/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: VACCINES | ||||||
| 09/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: DIABETES | ||||||
| 09/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: DIABETES | ||||||
| 08/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: Inflammation | ||||||
| 08/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Bone Health | ||||||
| 08/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Biological | ||||||
| 06/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Oncology | ||||||
| 06/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Inflammation | ||||||
| 05/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Diabetes Care | ||||||
| 04/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Diabetes | ||||||
| 04/08/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 718 | 973 | $175,578 | $66,009 |
| 2022 | 11 | 727 | 893 | $158,369 | $68,691 |
| 2021 | 9 | 700 | 895 | $142,540 | $64,353 |
| 2020 | 9 | 656 | 814 | $122,714 | $47,692 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 182 | 182 | $45,136 | $22,242 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 189 | 335 | $57,620 | $17,393 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 202 | $49,086 | $14,974 | 30.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $7,950 | $4,219 | 53.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 50 | 50 | $7,336 | $3,518 | 48.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 49 | 49 | $2,838 | $1,401 | 49.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 29 | $3,074 | $1,110 | 36.1% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 17 | 19 | $1,178 | $592.64 | 50.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $840.00 | $429.00 | 51.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 24 | 29 | $232.00 | $98.89 | 42.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 48 | $288.00 | $30.73 | 10.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 165 | 165 | $38,252 | $20,477 | 53.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 142 | 193 | $41,282 | $14,983 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 174 | 284 | $41,813 | $14,572 | 34.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 31 | 31 | $15,918 | $8,631 | 54.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 45 | 45 | $6,300 | $3,084 | 49.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 19 | 19 | $6,015 | $3,032 | 50.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 45 | 45 | $2,520 | $1,212 | 48.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 38 | 38 | $1,840 | $1,029 | 55.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 23 | 25 | $2,218 | $915.90 | 41.3% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 22 | 23 | $2,011 | $669.83 | 33.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 23 | 25 | $200.00 | $85.83 | 42.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 175 | 175 | $38,325 | $22,180 | 57.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 191 | 316 | $43,292 | $18,155 | 41.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 163 | 228 | $46,056 | $17,147 | 37.2% |
About Dr. Michael Punnett, MD
Dr. Michael Punnett, MD is a Family Medicine healthcare provider based in Crestwood, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619968013.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Punnett, MD has received a total of $4,431 in payments from pharmaceutical and medical device companies, with $529.01 received in 2024. These payments were reported across 293 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($4,426).
As a Medicare-enrolled provider, Punnett has provided services to 2,801 Medicare beneficiaries, totaling 3,575 services with total Medicare billing of $246,745. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Hospitalist, Family Medicine
- Location Crestwood, KY
- Active Since 11/03/2005
- Last Updated 12/08/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1619968013
Products in Payments
- XARELTO (Drug) $225.50
- FARXIGA (Drug) $222.46
- Ozempic (Drug) $185.71
- EVENITY (Biological) $185.26
- Synthroid (Drug) $154.40
- JARDIANCE (Drug) $151.01
- VRAYLAR (Drug) $135.77
- TRELEGY ELLIPTA (Drug) $133.42
- Prolia (Biological) $133.29
- Aimovig (Biological) $96.32
- Androgel (Drug) $84.88
- Otezla (Drug) $81.61
- CHANTIX (Drug) $76.64
- ANORO (Drug) $75.21
- Uloric (Drug) $72.04
- MYDAYIS (Drug) $70.74
- Victoza (Drug) $67.00
- INVOKANA (Drug) $64.21
- LYRICA (Drug) $59.73
- TRULICITY (Drug) $58.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Crestwood
Dr. Antonio Noriega, Md, MD
Family Medicine — Payments: $9,663
Richard Hefner, D.o, D.O
Family Medicine — Payments: $4,813
Jianxia Wang
Family Medicine — Payments: $1,383
Ebony Johnson, Md, MD
Family Medicine — Payments: $902.77
Kaveh Rahmani, Do, DO
Family Medicine — Payments: $840.65
Renee Girdler, Md, MD
Family Medicine — Payments: $806.43